Tuning Ligand Density To Optimize Pharmacokinetics of Targeted Nanoparticles for Dual Protection against Tumor-Induced Bone Destruction

Journal: ACS Nano

Published: 2020-01-08

DOI: 10.1021/acsnano.9b04571

Affiliations: 7

Authors: 12

Go to article
Institutions Share
Vanderbilt University (VU), United States of America (USA) 0.69
Vanderbilt University Medical Center (VUMC), United States of America (USA) 0.19
VA Tennessee Valley Healthcare System, United States of America (USA) 0.12